Leerink Partners Downgrades Progyny to Market Perform, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners has downgraded Progyny (NASDAQ:PGNY) from Outperform to Market Perform and lowered its price target from $31 to $25.
August 07, 2024 | 10:35 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Leerink Partners downgraded Progyny from Outperform to Market Perform and reduced the price target from $31 to $25.
The downgrade from Outperform to Market Perform and the reduction in the price target from $31 to $25 by Leerink Partners is likely to negatively impact Progyny's stock price in the short term as it reflects a less optimistic outlook from a reputable analyst.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100